The model could shift which patients receive gene expression profiling assays but might not change the number of tests ordered.
Using data from the Simons Simplex Collection, researchers estimated that 5 percent of autism spectrum disorder cases may involve mosaic de novo mutations.
The Albert and Mary Lasker Foundation has announced this year's recipients of its prizes honoring basic and clinical research.
Researchers found that mutations in this gene increased the risk of chronic obstructive pulmonary disease, bone marrow failure, and other conditions.
In counting defective proviruses, approaches for estimating the size of HIV patients' virus reservoirs are throwing off estimates of treatment effectiveness.
Tufts scientists and their colleagues called for steps to ensure that disadvantaged groups benefit from genetically based diagnoses and treatments.
A renal cell carcinoma study revealed increased metabolic gene expression in PD-L1-positive tumors from individuals who did not respond to nivolumab.
Considering the widespread use of the cell line, these findings could have significant implications for the research community.
A clear unmet clinical need coupled with the persuasive study data suggests that it shouldn't be long before this type of testing is made available clinically.
Researchers also uncovered key pathways and alterations linked to differences in survival.
At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.
The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.
Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.
In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.